What is the role of antiplatelet therapy in the management of posterior cerebral artery (PCA) stroke?

Updated: Jul 30, 2018
  • Author: Erek K Helseth, MD; Chief Editor: Helmi L Lutsep, MD  more...
  • Print

When no cause for recurrent strokes can be found, antiplatelet therapy—eg, with aspirin, ticlopidine, clopidogrel, or aspirin plus extended-release dipyridamole (Aggrenox)—is generally recommended instead of anticoagulation therapy.

As a result, patients entering the rehabilitation phase of their hospital course may be prescribed an anticoagulant, clopidogrel, or aspirin. The selection of these agents is dependent on the etiology of the posterior cerebral artery (PCA) stroke, associated complications, comorbidities, and prior medical history. These medications are used to prevent further cerebral vascular ischemic events.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!